Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Access to device-aided therapies in advanced Parkinson's disease: navigating clinician biases, patient preference, and prognostic uncertainty
Abstract Device-aided therapies (DAT), which include deep brain stimulation and pump-
based continuous dopaminergic stimulation with either levodopa or apomorphine, are …
based continuous dopaminergic stimulation with either levodopa or apomorphine, are …
Invasive therapies for Parkinson's disease: an adapted excerpt from the guidelines of the German Society of Neurology
Background Parkinson's disease (PD) is characterized by hypokinetic motor symptoms,
tremor, and various non-motor symptoms with frequent fluctuations of symptoms in …
tremor, and various non-motor symptoms with frequent fluctuations of symptoms in …
Nationwide Retrospective Analysis of Combinations of Advanced Therapies in Patients With Parkinson Disease
Background and Objectives Advanced therapies (ATs; deep brain stimulation [DBS] or pump
therapies: continuous subcutaneous apomorphine infusion [CSAI], levodopa/carbidopa …
therapies: continuous subcutaneous apomorphine infusion [CSAI], levodopa/carbidopa …
Switching and combining device-aided therapies in advanced Parkinson's disease: a double centre retrospective study
D Georgiev, S Delalić, N Zupančič Križnar, A Socher… - Brain sciences, 2022 - mdpi.com
Background: Device-aided therapies (DAT), such as continuous subcutaneous
apomorphine infusion (CSAI), levodopa-carbidopa intestinal gel infusion (LCIG), and deep …
apomorphine infusion (CSAI), levodopa-carbidopa intestinal gel infusion (LCIG), and deep …
Long-term effect and reasons for switching and combining device-aided therapies in Parkinson's Disease
D Georgiev, M Trost - Neurologia i Neurochirurgia Polska, 2025 - journals.viamedica.pl
Introduction. In the advanced stages of Parkinson's disease (PD), when standard drug
adjustments fail to sufficiently improve patients' quality of life, device-aided therapies (DATs) …
adjustments fail to sufficiently improve patients' quality of life, device-aided therapies (DATs) …
[PDF][PDF] Parkinson's Disease: Current Treatment Modalities and Emerging Therapies
S Alotaibi, L Alfayez, M Alkhudhair - Cureus, 2024 - cureus.com
Herein, we review the literature on Parkinson's disease (PD) management and summarize
the progress in medical, surgical, and assisted therapeutic modalities for motor and non …
the progress in medical, surgical, and assisted therapeutic modalities for motor and non …
Device-Aided Therapies in Parkinson's Disease—Results from the German Care4PD Study
O Fründt, AM Hanff, A Möhl, T Mai, C Kirchner… - Brain Sciences, 2023 - mdpi.com
Data on the use of device-aided therapies (DATs) in people with Parkinson's disease (PwP)
are scarce. Analyzing data from the Care4PD patient survey, we (1) evaluated application …
are scarce. Analyzing data from the Care4PD patient survey, we (1) evaluated application …
[PDF][PDF] КОМБИНАЦИЯ ГЛУБОКОЙ СТИМУЛЯЦИИ МОЗГА И ИНТРАЕЮНАЛЬНОГО ВВЕДЕНИЯ ГЕЛЯ ЛЕВОДОПА/КАРБИДОПА/ЭНТАКАПОН В ЛЕЧЕНИИ …
РА Беккер, ЮВ Быков, АЮ Быкова - academia.edu
Актуальность: Болезнь Паркинсона (БП)—это тяжёлое, неизбежно прогрессирующее,
неврологическое расстройство из группы нейродегенеративных заболеваний (НДЗ) …
неврологическое расстройство из группы нейродегенеративных заболеваний (НДЗ) …
[PDF][PDF] Switching and combining device-aided therapies in advanced Parkinson's disease: a double centre retrospective study
MD Achinoam Socher, MD Tanya Gurevich… - 2022 - preprints.org
Background: Continuous subcutaneous apomorphine infusion (CSAI), levodopa-carbidopa
intestinal gel infusion (LCIG), and deep brain stimulation of the subthalamic nucleus (STN …
intestinal gel infusion (LCIG), and deep brain stimulation of the subthalamic nucleus (STN …